SOLICITATION NOTICE
U -- Development of a Surgeon General's Report on - Notice of Intent to Sole Source
- Notice Date
- 8/5/2015
- Notice Type
- Presolicitation
- NAICS
- 541611
— Administrative Management and General Management Consulting Services
- Contracting Office
- Department of Health and Human Services, Program Support Center, Division of Acquisition Management, 12501 Ardennes Avenue, Suite 400, Rockville, Maryland, 20857, United States
- ZIP Code
- 20857
- Solicitation Number
- SAM156590
- Point of Contact
- Flora Gomes,
- E-Mail Address
-
flora.gomes@psc.hhs.gov
(flora.gomes@psc.hhs.gov)
- Small Business Set-Aside
- N/A
- Description
- Development of a Surgeon General's Report on Alcohol Drugs and Health and Provision of Medical Scientific and Psychiatric Advice Notice of Intent to Sole Source: Pursuant to the authority of FAR 13.106-1(b)(1)(i), the Contracting Officer may solicit from one source if the Contracting Officer determines that the circumstances of the contract action deem only one source is reasonably available. The Department of Health and Human Services (DHHS), Program Support Center (PSC), Acquisition Management Services (AMS) on behalf of PSC, Substance Abuse and Mental Health Services Administration (SAMHSA) intends to sole source to: H. Westley Clark 17117 Briardale Derwood, MD 20855-2076 Substance Abuse and Mental Health Services Administration (SAMHSA), seeks to develop a Surgeon General's Report on Alcohol, Drugs, and Health; and Provision of Medical, Scientific, and Psychiatric Advice. SAMHSA has chosen Dr. H. Westley Clark as the chosen contractor. Dr. Westley has vast knowledge and experience that make him uniquely qualified to perform the work required under this purchase order. He is one of very few individuals who possess the subject matter expertise related to substance abuse treatment required to serve as a scientific editor of a Surgeon General's Report on Alcohol, Drugs, and Health. There has never been a Surgeon General's Report on Alcohol, Drugs, and Health. The Affordable Care Act and the Mental Health Parity and Addiction Equity Act have made major changes to the healthcare system, and as a result, 60 million Americans will be newly insured or benefit from equivalent protections to ensure they have coverage for substance abuse treatment services. Dr. Clark recently retired after 16 years as the Director of SAMHSA's Center for Substance Abuse Treatment (CSAT) and more than 30 years in the federal government. Dr. Clark's professional life is one marked by non-stop accomplishments and accolades (such as the American Medical Association's John P. McGovern Award, Presidential Rank Award, Vernelle Fox Award from the California Society of Addiction Medicine, Solomon Carter Fuller Award from the American Psychiatric Association, and multiple Awards for Distinguished Service from the HHS Secretary). His career has had significant impacts on the research, practice, policies and programs in the treatment of substance use disorders. Dr. Clark is a graduate of the chemistry program at Detroit's Wayne State University, the University of Michigan schools of medicine and public health, and Harvard law school. He also completed a two-year Substance Abuse Fellowship at the Department of Veteran Affairs Medical Center in San Francisco, where he served as Associate Clinical Professor, Department of Psychiatry, University of California at San Francisco (UCSF). He also served as senior program consultant to the Robert Wood Johnson Substance Abuse Policy Program and supported a number of National Institute of Drug Abuse-funded research grants. He received his board certification from the American Board of Psychiatry and Neurology in psychiatry and sub-specialty certifications in addiction psychiatry. Dr. Clark is licensed to practice medicine in California, Maryland, Massachusetts, and Michigan, and he a member of the Washington, D.C., Bar Association. Dr. Clark joined SAMHSA in 1998 to lead CSAT, arriving with an arsenal of knowledge that few in the addiction treatment field could match. Dr. Clark's work at SAMHSA from the very beginning demonstrated the depth and breadth of expertise for which he is known throughout the behavioral health community in the U.S. and abroad. During his tenure at SAMHSA, Dr. Clark led the agency's efforts to provide effective and accessible treatment to all Americans with addictive disorders. Additionally, Dr. Clark was a champion of the recovery movement. He helped to create the Recovery Community Services Programs, for recovery community organizations to help peers stay on the path to wellness. He was also involved in the development and implementation of Recovery-Oriented Systems of Care as well as the Presidential Initiative, Access to Recovery. As a staunch supporter of Recovery Month, each year, he travelled across the nation to deliver a message of hope and recovery to all Americans. Dr. Clark's background as a scientist as well as a practitioner equipped him with the knowledge that recovery is possible. In his daily work, Dr. Clark applied the latest in research findings and made the advancement of evidence-based treatment a priority in all aspects of CSAT's portfolio. He fostered robust partnerships with the National Institute of Drug Abuse and - through the Addiction Technology Transfer Centers, Treatment Improvement Protocols, Technical Assistance Publications, and other SAMHSA resources - created a science to service pipeline to ensure the latest research-based innovations such as Screening, Brief Intervention, and Referral to Treatment, Motivational Interviewing, and Medication Assisted Treatment got into the field as rapidly as possible. Dr. Clark is also a master of policy and legal issues. He worked closely with the White House Office of National Drug Control Policy on the implementation of the President's Drug Strategy, tackling important issues such as getting treatment to pregnant and post-partum women, reducing recidivism among individuals in the criminal justice system, and increasing choice of treatment options - including recovery support services - for individuals with substance use disorders. In the last few years, Dr. Clark took on a major leadership role in behavioral health information technology and led SAMHSA's partnering work with the Office of the National Coordinator for Health Information Technology to develop standards and data segmentation efforts for electronic health records, prescription drug monitoring programs (PDMPs), and health information exchanges. This pioneering work on HIT and 42 CFR Part 2 will help make critical information available for treatment and quality purposes while protecting and enhancing privacy protections. During his time at SAMHSA, Dr. Clark deftly navigated several controversies. One of the most memorable was the somewhat heated debate that took place over the introduction of buprenorphine as a medication assisted therapy for opioid addiction. To address the controversy, Dr. Clark developed a series of town hall meetings that reached out to physicians to answer questions and encourage them to become certified to prescribe the medication. His original goal was to certify 6,000 physicians within a 5-year period. At the end of those 5 years, SAMHSA had certified more than 12,000 physicians. Dr. Clark proved to be a tireless advocate for underserved and underrepresented communities struggling with addiction. He ensured SAMHSA's programs addressed issues of co-occurring mental and substance use disorders, HIV/AIDS and hepatitis, military families, rural and urban settings, LGBT, gender, and racial/ethnic disparities. He is well known for stating that there are many pathways to recovery, and he made sure that SAMHSA and its programs were prepared to support them. Due to the above reasons, Dr. Dr. Clark is the best individual to support the development of a Surgeon General's Report on Alcohol, Drugs, and Health; and Provision of Medical, Scientific, and Psychiatric Advice. This is not a solicitation for competitive proposal. No solicitation document is available. All responsible sources that have determined that they can provide the same services may submit product information and a capabilities statement addressing their specific abilities regarding this requirement. The email subject line must reference SAM156590. All responses are due by August 20, 2015, 8:00 AM Eastern Time and can be sent to Flora Gomes at flora.gomes@psc.hhs.gov. A determination by the Government not to compete this proposed contract base upon responses to this notice is solely within the discretion of the government.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/PSC/DAM/SAM156590/listing.html)
- Record
- SN03824700-W 20150807/150805235033-da35b0abdb2936a6f70ec96d59cdda30 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |